GSK

1,874

-0.49%↓

GSK

1,874

-0.49%↓

GSK

1,874

-0.49%↓

GSK

1,874

-0.49%↓

GSK

1,874

-0.49%↓

Home・Aandelen Lijst・Pets at Home Group Plc
Search

Pets at Home Group Plc

Gesloten

SectorGezondheidszorg

183.6 2.17

Neutraal

Prijsupdate 1 mei 2026, 15:29 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

183.1

Max

183.7

Belangrijke statistieken

By Trading Economics

Inkomsten

26M

Verkoop

778M

K/W

Sectorgemiddelde

10.47

51.415

EPS

0.056

Dividendrendement

7.24

Winstmarge

3.366

Werknemers

11,597

EBITDA

102M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+25.43% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

7.24%

2.34%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

787M

Vorige openingsprijs

181.43

Vorige sluitingsprijs

183.6

Nieuwssentiment

By Acuity

50%

50%

162 / 346 Rangschikking in Healthcare

Pets at Home Group Plc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

13 mei 2026, 22:54 UTC

Winsten

Xero Lifts Annual Earnings 18%, Flags More Growth Ahead

DJ

Lezen

13 mei 2026, 23:51 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lezen

13 mei 2026, 23:51 UTC

Marktinformatie

Australian Consumer Spending Is Holding Up; RBA Watching -- Market Talk

DJ

Lezen

13 mei 2026, 23:45 UTC

Marktinformatie

Nikkei May Rise After Overnight U.S. Tech Gains -- Market Talk

DJ

Lezen

13 mei 2026, 23:45 UTC

Marktinformatie

Global Equities Roundup: Market Talk

DJ

Lezen

13 mei 2026, 23:17 UTC

Winsten

Samsung Fire & Marine Insurance 1Q Net Profit Beat FactSet-Compiled Consensus

DJ

Lezen

13 mei 2026, 23:16 UTC

Winsten

Samsung Fire & Marine Insurance 1Q Net KRW635.22B Vs. Net KRW609.03B >000810.SE

DJ

Lezen

13 mei 2026, 23:15 UTC

Winsten

Samsung Fire & Marine Insurance 1Q Oper Pft KRW861.13B Vs. Pft KRW792.36B >000810.SE

DJ

Lezen

13 mei 2026, 23:14 UTC

Winsten

Samsung Fire & Marine Insurance 1Q Rev KRW6.676T Vs. KRW6.106T >000810.SE

DJ

Lezen

13 mei 2026, 23:02 UTC

Marktinformatie
Winsten

Cisco Product Demand Climbing Even Without Hyperscalers -- Market Talk

DJ

Lezen

13 mei 2026, 22:59 UTC

Marktinformatie
Winsten

Cisco Boosted by Tech Infrastructure Upgrade Cycle -- Market Talk

DJ

Lezen

13 mei 2026, 22:24 UTC

Winsten

Xero FY U.S. Organic Revenue Growth 30%>XRO.AU

DJ

Lezen

13 mei 2026, 22:23 UTC

Winsten

Xero FY International Organic Revenue Growth 25%>XRO.AU

DJ

Lezen

13 mei 2026, 22:23 UTC

Winsten

Xero FY International Revenue Growth 47%>XRO.AU

DJ

Lezen

13 mei 2026, 22:22 UTC

Winsten

Xero FY Australia, New Zealand Revenue Up 18% on Year >XRO.AU

DJ

Lezen

13 mei 2026, 22:19 UTC

Winsten

Xero FY Australia, New Zealand Revenue Up 17% in Constant Currency>XRO.AU

DJ

Lezen

13 mei 2026, 22:19 UTC

Winsten

Xero FY Net Customer Additions 506,000 Vs. 254,000>XRO.AU

DJ

Lezen

13 mei 2026, 22:18 UTC

Winsten

Xero FY Rule of 40: 48.5% Vs. 44.3%>XRO.AU

DJ

Lezen

13 mei 2026, 22:16 UTC

Winsten

Xero: Ebitda Guidance Includes NZD55M of Incremental U.S. Brand Spend>XRO.AU

DJ

Lezen

13 mei 2026, 22:15 UTC

Winsten

Xero Expects FY27 Adjusted Ebitda of NZD860M-NZD920M>XRO.AU

DJ

Lezen

13 mei 2026, 22:15 UTC

Winsten

Xero Expects FY27 Operating Revenue of NZD3.62B-NZD3.73B>XRO.AU

DJ

Lezen

13 mei 2026, 22:13 UTC

Winsten

Xero FY Operating Expenses 70.5% of Operating Revenue Vs. 71.8%>XRO.AU

DJ

Lezen

13 mei 2026, 22:12 UTC

Winsten

Xero FY Free Cash Flow NZD554.0M Vs. NZD506.7M>XRO.AU

DJ

Lezen

13 mei 2026, 22:11 UTC

Winsten

Xero FY Adjusted Ebitda NZD757.4M Vs. NZD641.8M>XRO.AU

DJ

Lezen

13 mei 2026, 22:11 UTC

Winsten

Xero FY Ebitda NZD789.5M Vs. NZD638.5M>XRO.AU

DJ

Lezen

13 mei 2026, 22:10 UTC

Winsten

Xero Did Not Declare a Dividend>XRO.AU

DJ

Lezen

13 mei 2026, 22:10 UTC

Winsten

Xero FY Rev NZD2.75B Vs. NZD2.10B >XRO.AU

DJ

Lezen

13 mei 2026, 22:09 UTC

Winsten

Xero FY Net NZD167.4M Vs. Net NZD227.8M >XRO.AU

DJ

Lezen

13 mei 2026, 22:00 UTC

Winsten

Cisco to Shed Jobs for All-In AI Push -- Update

DJ

Lezen

13 mei 2026, 21:11 UTC

Winsten

Cisco Earnings and Revenue Beat Estimates on Strong AI Demand. Its Shares Surge. -- Barrons.com

DJ

Lezen

Peer Vergelijking

Prijswijziging

Pets at Home Group Plc Prognose

Koersdoel

By TipRanks

25.43% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 221.25 GBX  25.43%

Hoogste 265 GBX

Laagste 170 GBX

Gebaseerd op 4 Wall Street-analisten die 12-maands prijsdoelen bieden voor Pets at Home Group Plc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

4 ratings

2

Buy

1

Hold

1

Sell

Gebaseerd op 4 analisten die aandelenratings hebben gegeven aan Pets at Home Group Plc - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

162 / 346 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Pets at Home Group Plc

Pets at Home Group Plc engages in the specialist omnichannel retailing of pet food, pet related products, and pet accessories in the United Kingdom. It operates through three segments: Retail, Vet Group, and Central. The company offers pet grooming services comprising a full dog groom, bath and blow dry, microchipping, and nail clipping; and pet insurance products, as well as other in-store services, including consultations with its trained pet nutritionists. Further, it offers general veterinary care; triage; and veterinary telehealth services. The company operates through pet care centers, stores, general practices, and grooming salons. It also provides products and services through online under the Pet at Home, Vets for Pets, Pet Grooming, Pets Foundation, and Pets VIP Club brands. Pets at Home Group Plc was founded in 1991 and is based in Handforth, the United Kingdom.

Andere aandelen uit de sector

GSK

GlaxoSmithKline PLC

1,874

↓-0.49%
help-icon Live chat